San Francisco Bay Area - Palo Alto California | U.S.A.
| Investor Type | Firm |
| Industries | Software (Web Marketplace Saas..) • BioTech • IoT (& Wearables) • A.I. (& Big Data) • HealthTech (& Fitness) • Cloud Services (& Infrastructure) • Future Of Work • Medical Devices (& Hospital Services) • Robotics • DeepTech • Healthcare (& Wellness) • Consumer |
| Stages | Seed, Series A, Series B |
| Investing | United States |
| Investment Range | $1,000,000 - $3,000,000 |
| Investment Sweet Spot | $2,000,000 |
| Assets Under Management | $350,000,000 |
About The Fund
Dimension Capital is an avant-garde investment firm that operates at the crossroads of technology and life sciences, with the mission to reshape the future trajectory of life on earth. They stand out as a firm that fuels the synergy between the infinite possibilities that emerge when combining computational power with biological sciences. Dimension Capital collaborates with innovative entrepreneurs aiming to cultivate the next generation of businesses in tech and biotech domains. They concentrate their investments in sectors such as Software (including Web Marketplace SaaS, etc.), Biotech, IoT and Wearables, AI and Big Data, HealthTech and Fitness, Cloud Services and Infrastructure, Future Of Work, Medical Devices and Hospital Services, Robotics, DeepTech, Healthcare and Wellness, and the broader Consumer space. Dimension Capital showcases investment propositions that typically range from $1,000,000 to $3,000,000, with their preferred 'sweet spot' being around $2,000,000. Their expertise is rooted in early-stage ventures, specifically in Seed, Series A, and Series B rounds. They are an active participatory fund with assets under management worth $350,000,000. Their portfolio features companies such as Aspect Biosystems, tackling the domain of regenerative medicines; Chai Discovery with AI foundation models for predicting and reprogramming molecular interactions; and Monte Rosa Therapeutics with applications of geometric deep learning in the creation of novel therapeutics. Through 'Dimension II', they have reaffirmed their commitment to accelerated overlapping science and technology curves. Dimension Capital maintains a dynamic conversation with the investment and scientific community through their research, insights, and perspectives shared on various platforms. Their website features articles, videos, and announcements that represent the breadth and depth of their engagement with the sectors they invest in.
Dimension Capital's investments on record
Contact over 100,000 investors!
Built by serial entrepreneurs and ex-VCs, Angels Partners helps entrepreneurs connect with relevant investors in their industry.
With over 100K+ listed investors, our mission is to help founders secure meetings & accelerate their fundraising.
View previous deals, filter by deal size, industry, location and more. It's the fastest way to build a target investor list.
e
We also built a community of hundreds of investors actively prospecting & investing directly on Angels Partners.
Register to become visible to a large community of investors on our platform.
- Prime Founders
- 85 Great Portland St.
- London, U.K.
- contact@angelspartners.com
